AD
Ayala Pharmaceuticals, Inc.
ADXS · OTC
$0.60 +0.00% (+$0.00)
Market Cap $6.31M
P/E Ratio 0.26x
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
72 /100
Cheap PEG 1.50x
P/S 0.09x
P/B 0.07x
Growth
4 /100
Declining Book val. growth 1.03%
Rev. growth 9.81%
FCF growth N/A
Profitability
57 /100
Moderate Net margin 17.63%
Op. margin 59.47%
Gross margin 94.85%
Quality
14 /100
Poor ROA 4.48%
Asset turnover 0.25x
ROIC 33.02%
Debt
45 /100
Moderate Current ratio 3.91x
Int. coverage 1.26x
Net debt/EBITDA 2.76x
Stability
45 /100
Moderate Rev. volatility 10.59%
EPS volatility 6,761.11%
Profitable years 2
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ADXS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kenneth A. Berlin
Employees
20
Headquarters
Monmouth Junction